Finzati - Logo
CI logo

Cigna Corporation

CI • Medical - Healthcare Plans
$306.60
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$80.93B
Growth
—
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 19.0%Positive free cash flow · 31.54Consistent free cash flow · 5/5Reasonable earnings multiple · 12.29Manageable debt level · 0.75
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$306.60
Change0.00%
Shares Out263.96M
Market Cap$80.93B
Enterprise Value$106.51B
52W Range239.51 - 315.47
Beta0.30
P/E12.61
P/S0.29
P/B1.90
P/FCF8.88
EV/Sales0.38

Investment DNA

How strong this company looks for long-term investors

69
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
52/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
90/100
Why this score▼
Positive revenue growth · 19.0%Positive free cash flow · 31.54Consistent free cash flow · 5/5Reasonable earnings multiple · 12.29Manageable debt level · 0.75Weak liquidity · 0.85

Analyst view

Analyst sentiment and price target

CI
Analyst sentiment
Based on 39 analyst votes · 2026-10-20
86/100
Bullish
Bullish
28
Hold
11
Bearish
0
Price Target
2026-07-31
Low
$302.00
Mean
$341.82
Median
$340.00
High
$400.00

Company Overview

IPO: 3/31/1982
Industry: Medical - Healthcare Plans
P/B i: 1.90
Debt / Equity i: 0.75
Operating Margin: 3.32%
Net Margin: 2.17%
ROE i: -
ROIC: -

Financial Health

Score10 / 20
Debt / Equity: 0.75
Current Ratio: 0.85
Quick Ratio: 0.72
Status: Moderate

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Perlberg Matthew
Transaction: 03/01/2027
OTHER
Change
+4,643
Price
$287.55
Filing
07/09/2026
Type
OTHER
Sadler Jason D
Transaction: 03/01/2027
OTHER
Change
+3,564
Price
$287.55
Filing
07/09/2026
Type
OTHER
Kautzner Adam
Transaction: 03/01/2027
OTHER
Change
+5,628
Price
$287.55
Filing
07/09/2026
Type
OTHER